Filters: Author is Paul F. Jacques  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
B
C
Cheng S, Massaro JM, Fox CS, et al. "Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study." Diabetes. 2010;59:242-248. Abstract
D
Dietrich M, Jacques PF, Polak JF, et al. "Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study." Journal of Stroke and Cerebrovascular Diseases: The Official Journal of National Stroke Association. 2011;20:155-161. Abstract
E
Elias MF, Sullivan LM, D'Agostino RB, et al. "Homocysteine and cognitive performance in the Framingham offspring study: age is important." American Journal of Epidemiology. 2005;162:644-653. Abstract
Erkkilä AT, Booth SL, Hu FB, et al. "Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women." European Journal of Clinical Nutrition. 2005;59:196-204. Abstract
Erkkilä AT, Lichtenstein AH, Jacques PF, Hu FB, Wilson PWF, Booth SL. "Determinants of plasma dihydrophylloquinone in men and women." The British Journal of Nutrition. 2005;93:701-708. Abstract
Erkkilä AT, Booth SL, Hu FB, Jacques PF, Lichtenstein AH. "Phylloquinone intake and risk of cardiovascular diseases in men." Nutrition, Metabolism, and Cardiovascular Diseases: {NMCD}. 2007;17:58-62. Abstract
F
H
I